SMSPHARMA

Sms Pharmaceuticals Share PriceSMS Pharmaceuticals

₹118.4
-0.6 (-0.5%)
As on 01 December, 2023 | 02:09 BSE: 532815 NSE: SMSPHARMAISIN: INE812G01025

Sms Pharmaceuticals Performance

Day Range

  • Low 117.20
  • High 119.85
₹ 118.4

52 Week Range

  • Low 54.55
  • High 140.00
₹ 118.4
  • Open Price119.05
  • Previous Close119.00
  • Volume66901

Start SIP in SMS Pharmaceuticals

Start SIP

Sms Pharmaceuticals Share Price

  • Over 1 Month 1.15%
  • Over 3 Month -8.15%
  • Over 6 Month 42.48%
  • Over 1 Year 38.48%

Sms Pharmaceuticals Key Statistics

P/E Ratio 32.3
PEG Ratio 0
Market Cap Cr 1,002
Price to Book Ratio 2.2
EPS 0.5
Dividend 0.3
Relative Strength Index 46.84
Money Flow Index 55.28
MACD Signal -0.36
Average True Range 3.82

Sms Pharmaceuticals Investment Rating

  • Master Rating:
  • Sms Pharmaceuticals has an operating revenue of Rs. 600.21 Cr. on a trailing 12-month basis. An annual revenue de-growth of 0% needs improvement, Pre-tax margin of 1% needs improvement, ROE of -1% is poor and needs improvement. The company has a reasonable debt to equity of 26%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and around 20% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 15% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 69 which is a FAIR score but needs to improve its earnings, a RS Rating of 62 which is FAIR indicating the recent price performance, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 69 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock definitely has some strength, you may want to examine it in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

SMS Pharmaceuticals Financials
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 1671351491491596461
Operating Expenses Qtr Cr 1391091261311466565
Operating Profit Qtr Cr 28272318140-4
Depreciation Qtr Cr 8888888
Interest Qtr Cr 6666554
Tax Qtr Cr 34310-3-25
Net Profit Qtr Cr 129851-109
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 527525
Operating Expenses Annual Cr 467405
Operating Profit Annual in Cr 55114
Depreciation Cr 3232
Interest Annual Cr 2219
Tax Annual Cr 11
Net Profit Annual Cr 468
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 2240
Cash from Investing Activity Annual Cr -30-27
Cash from Financing Annual Activity Cr -32-7
Net Cash Flow Annual Cr -396
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 495494
Fixed Assets Annual Cr 445449
Total Non Current Assets Annual Cr 504506
Total Current Assets Annual Cr 411377
Total Assets Annual Cr 914883
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 5858
ROE Annual % 114
ROCE Annual % 413
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 1123
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 1671351491491596461
Operating Expenses Qtr Cr 1391091261301466565
Operating Profit Qtr Cr 2826231914-1-4
Depreciation Qtr Cr 8888888
Interest Qtr Cr 6666554
Tax Qtr Cr 34310-3-25
Net Profit Qtr Cr 12964-2-136
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 527525
Operating Expenses Annual Cr 468406
Operating Profit Annual in Cr 55114
Depreciation Cr 3232
Interest Annual Cr 2219
Tax Annual Cr 11
Net Profit Annual Cr -762
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 2240
Cash from Investing Activity Annual Cr -30-27
Cash from Financing Annual Activity Cr -32-7
Net Cash Flow Annual Cr -396
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 461470
Fixed Assets Annual Cr 445449
Total Non Current Assets Annual Cr 469482
Total Current Assets Annual Cr 411377
Total Assets Annual Cr 880860
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 5456
ROE Annual % -213
ROCE Annual % 413
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 1123

Sms Pharmaceuticals Technicals

EMA & SMA

Current Price
₹118.4
-0.6 (-0.5%)
pointer
  • Bullish Moving Average
  • ___
  • 4
  • Bearish Moving Average
  • ___
  • 12
  • 20 Day
  • ₹119.44
  • 50 Day
  • ₹119.65
  • 100 Day
  • ₹115.56
  • 200 Day
  • ₹107.09
  • 20 Day
  • ₹119.46
  • 50 Day
  • ₹120.47
  • 100 Day
  • ₹119.90
  • 200 Day
  • ₹99.25

Sms Pharmaceuticals Resistance and Support

PIVOT
₹118.49
Resistance
First Resistance 119.77
Second Resistance 121.13
Third Resistance 122.42
RSI 46.84
MFI 55.28
MACD Single Line -0.36
MACD -0.21
Support
First Resistance 117.12
Second Resistance 115.83
Third Resistance 114.47

Sms Pharmaceuticals Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 78,908 4,680,823 59.32
Week 195,937 11,123,358 56.77
1 Month 148,390 7,630,194 51.42
6 Month 172,895 8,113,956 46.93

Sms Pharmaceuticals Result Highlights

SMS Pharmaceuticals Synopsis

NSE-Medical-Generic Drugs

Sms Pharmaceuticals is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 522.05 Cr. and Equity Capital is Rs. 8.47 Cr. for the Year ended 31/03/2023. SMS Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 14/12/1987 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L24239TG1987PLC008066 and registration number is 008066.
Market Cap 1,002
Sales 600
Shares in Float 3.05
No of funds 4
Yield 0.25
Book Value 2.03
U/D Vol ratio 2
LTDebt / Equity 24
Alpha 0.12
Beta 0.78

SMS Pharmaceuticals

Owner NameSep-23Jun-23Mar-23Dec-22
Promoters 64.32%64.32%64.29%64.17%
Mutual Funds
Foreign Portfolio Investors 0.6%0.67%0.59%0.59%
Individual Investors 29.07%29.04%29.01%28.82%
Others 6.01%5.97%6.11%6.42%

SMS Pharmaceuticals Management

Name Designation
Mr. Ramesh Babu Potluri Chairman & Managing Director
Mr. Vamsi Krishna Potluri Executive Director
Mr. Sarath Kumar Pakalapati Independent Director
Mr. Sharvan Kudaravalli Independent Director
Mr. Sarvepalli Srinivas Independent Director
Dr.(Mrs.) Neelaveni Thummala Independent Director

Sms Pharmaceuticals Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Sms Pharmaceuticals Corporate Action

Date Purpose Remarks
2023-11-08 Quarterly Results
2023-08-08 Quarterly Results
2023-05-24 Audited Results & Final Dividend
2023-02-09 Quarterly Results
2022-11-12 Quarterly Results
Date Purpose Remarks
2023-09-22 FINAL Rs.0.30 per share(30%)Final Dividend
2022-09-23 FINAL Rs.0.30 per share(30%)Final Dividend

SMS Pharmaceuticals MF Shareholding

Name Amount(cr)
Motilal Oswal S&P BSE Healthcare ETF 8

SMS Pharmaceuticals FAQs

What is Share Price of SMS Pharmaceuticals ?

SMS Pharmaceuticals share price is ₹118 As on 01 December, 2023 | 01:55

What is the Market Cap of SMS Pharmaceuticals ?

The Market Cap of SMS Pharmaceuticals is ₹1002.3 Cr As on 01 December, 2023 | 01:55

What is the P/E ratio of SMS Pharmaceuticals ?

The P/E ratio of SMS Pharmaceuticals is 32.3 As on 01 December, 2023 | 01:55

What is the PB ratio of SMS Pharmaceuticals ?

The PB ratio of SMS Pharmaceuticals is 2.2 As on 01 December, 2023 | 01:55

Q2FY23